NCT05888493
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05888493
Title A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma (LEDA)
Acronym LEDA
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries SVK | POL | HUN | ESP | CZE | CAN | AUT | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Camperdown New South Wales 2050 Australia Details
Novartis Investigative Site Clayton Victoria 3168 Australia Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Montreal Quebec H1T 2M4 Canada Details
Novartis Investigative Site Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site Budapest H-1097 Hungary Details
Novartis Investigative Site Poznan Greater Poland Voivodeship 60-355 Poland Details
Novartis Investigative Site Gliwice Silesian Voivodeship 44-101 Poland Details
Novartis Investigative Site Gdansk 80-952 Poland Details
Novartis Investigative Site Lodz 93-513 Poland Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Bratislava 83310 Slovakia Details
Novartis Investigative Site Seoul Korea 03080 South Korea Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Seoul 05505 South Korea Details
Novartis Investigative Site Seoul 06351 South Korea Details
Novartis Investigative Site Seoul 06591 South Korea Details
Novartis Investigative Site Santiago Compostela A Coruna 15706 Spain Details
Novartis Investigative Site L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Novartis Investigative Site Santander Cantabria 39008 Spain Details
Novartis Investigative Site El Palmar Murcia 30120 Spain Details
Novartis Investigative Site Barcelona 08035 Spain Details
Novartis Investigative Site Córdoba 14004 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Salamanca 37007 Spain Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Taichung 407219 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field